Associate Member
Moffitt Cancer Center
Tampa, Florida, United States
Dr. Andrew (Andy) Brohl is a medical oncologist and physician-scientist. His clinical interest is in the care of patients with rare cancers including sarcoma and Merkel cell carcinoma. Dr. Brohl’s laboratory research focuses on the utilization of genomics and other high-throughput technologies for biological discovery and translational applications. Dr. Brohl earned his MD degree from the University of Miami, Miller School of Medicine. He completed an Internal Medicine Residency at Georgetown University and a Hematology and Medical Oncology Fellowship at the National Cancer Institute. He joined Moffitt in 2015 from the Icahn School of Medicine at Mount Sinai where he held dual academic appointments in the Department of Genetics and Genomic Science and the Division of Hematology and Medical Oncology. Dr. Brohl has received numerous academic awards including graduation with research distinction and magna cum laude from Duke University. Also while at Duke, he was named to the Tau Beta Pi engineering honor society, was selected as a Pratt Engineering Undergraduate Fellow, and graduated with dual majors in Biomedical Engineering and Mathematics. During medical school, he was recognized for academic and service contributions, including post-Hurricane Katrina volunteer efforts in southern Mississippi, and was named to the Alpha Omega Alpha medical honor society. He received the "Clinical Sciences Top Publication" award at Moffitt in 2022 for his senior author paper in Lancet. Dr. Brohl is currently a member of several professional associations, including the American Association for Cancer Research, Connective Tissue Oncology Society, the Society for Immunotherapy of Cancer, and the American Society of Clinical Oncology.
Disclosure information not submitted.
